Cortalix is a biotechnological company developing PET-imaging diagnostics, targeted radiotherapeutics, CAR-T immunotherapeutics.
Cortalix has raised $1.1M in total funding. The most recent round was Seed. The last funding was announced in March 2025.
Cortalix's investors include Rabobank, Future Tech Ventures.
Cortalix is headquartered in Groningen, The Netherlands.
Cortalix is a biotechnological company developing PET-imaging diagnostics, targeted radiotherapeutics, CAR-T immunotherapeutics.
Cortalix is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cortalix — Funding & Investors." VCBacked, March 10, 2025, https://www.vcbacked.co/company/cortalix. Accessed August 1, 2026.
VCBacked. (2025). Cortalix — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/cortalix
{{cite web |title=Cortalix — Funding & Investors |url=https://www.vcbacked.co/company/cortalix |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated